OTEZLA
Live / Registered — Registered and renewed (as of 16 Oct 2024)
What this means for you
Registered since 02 Sept 2014. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 02 Sept 2024).
Record
- Serial number
- 86109590
- Registration number
- 4598910
- Mark type
- Design + words
- Filed
- 04 Nov 2013
- Published for opposition
- 18 Mar 2014
- Registered
- 02 Sept 2014
- Next maintenance due
- 02 Sept 2024
- Attorney of record
- Elsa D. Lemoine
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system; pharmaceutical preparations for the treatment of chronic inflammatory diseases, ankylosing spondylitis, psoriasis, psoriatic arthritis and cancer
Owner
- AMGEN INC., Thousand Oaks, CA, US
- Celgene Corporation, Summit, NJ, US
- Celgene Corporation, Summit, NJ, US
- Celgene Corporation, Summit, NJ, US
Prior registrations
Prosecution history
- 25 Feb 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 25 Feb 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 25 Feb 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 25 Feb 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 25 Feb 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 16 Oct 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 16 Oct 2024 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 16 Oct 2024 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 16 Oct 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 23 Jul 2024 — TEAS SECTION 8 & 9 RECEIVED
- 02 Sept 2023 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 19 Jun 2020 — REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
- 27 May 2020 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 27 May 2020 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 27 May 2020 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS